StockNews.com Initiates Coverage on Atrion (NASDAQ:ATRI)

Equities research analysts at StockNews.com started coverage on shares of Atrion (NASDAQ:ATRIGet Free Report) in a research report issued on Sunday. The brokerage set a “sell” rating on the medical instruments supplier’s stock.

Atrion Trading Down 0.0 %

Shares of ATRI opened at $459.66 on Friday. Atrion has a 12 month low of $274.98 and a 12 month high of $503.24. The firm has a fifty day simple moving average of $455.77 and a 200 day simple moving average of $428.16. The stock has a market capitalization of $809.00 million, a price-to-earnings ratio of 43.20 and a beta of 0.69.

Atrion (NASDAQ:ATRIGet Free Report) last announced its earnings results on Thursday, August 8th. The medical instruments supplier reported $0.23 EPS for the quarter. Atrion had a net margin of 10.60% and a return on equity of 7.75%. The business had revenue of $48.77 million during the quarter.

Hedge Funds Weigh In On Atrion

Several large investors have recently modified their holdings of ATRI. Quadrant Capital Group LLC acquired a new position in shares of Atrion in the fourth quarter valued at about $36,000. Headlands Technologies LLC bought a new position in Atrion in the 2nd quarter valued at approximately $54,000. Benjamin F. Edwards & Company Inc. bought a new position in Atrion during the 2nd quarter worth approximately $72,000. EntryPoint Capital LLC bought a new position in Atrion during the 1st quarter worth approximately $91,000. Finally, Comerica Bank raised its holdings in Atrion by 60.9% during the 1st quarter. Comerica Bank now owns 415 shares of the medical instruments supplier’s stock worth $192,000 after purchasing an additional 157 shares during the last quarter. 66.19% of the stock is owned by institutional investors.

Atrion Company Profile

(Get Free Report)

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmic applications in the United States, Canada, Europe, and internationally. The company's fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments.

Featured Articles

Receive News & Ratings for Atrion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atrion and related companies with MarketBeat.com's FREE daily email newsletter.